StockData
Cencora, Inc. logo

Cencora, Inc. (COR) stock

CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3021% above fair value
$348.31−2.25 (-0.64%)

Close on Nov 18, 2026Market cap $66.47BP/E 25.9Yield 0.63%

Cencora net income

Net income is the profit left for shareholders after every expense, interest and tax.

Cencora's net income for the twelve months ending Jun 30, 2026 was $2.62B, up 38.3% year over year. For fiscal 2025 it was $1.55B, up 3.0% from the year before. The highest annual figure on record is $1.75B in fiscal 2023.

Annual net income

PeriodPeriod endValueChange
FY2025Sep 30, 2025$1.55B+3.0%
FY2024Sep 30, 2024$1.51B-13.5%
FY2023Sep 30, 2023$1.75B+2.7%
FY2022Sep 30, 2022$1.70B+10.3%
FY2021Sep 30, 2021$1.54B–
FY2020Sep 30, 2020-$3.41B-498.5%
FY2019Sep 30, 2019$855.37M-48.4%
FY2018Sep 30, 2018$1.66B+355.0%
FY2017Sep 30, 2017$364.48M-74.5%
FY2016Sep 30, 2016$1.43B–
FY2015Sep 30, 2015-$138.17M-150.4%
FY2014Sep 30, 2014$274.23M-36.8%
FY2013Sep 30, 2013$433.71M-39.7%
FY2012Sep 30, 2012$718.99M+1.7%
FY2011Sep 30, 2011$706.62M+11.0%
FY2010Sep 30, 2010$636.75M+26.5%
FY2009Sep 30, 2009$503.40M+100.9%
FY2008Sep 30, 2008$250.56M-46.6%
FY2007Sep 30, 2007$469.17M–

Quarterly net income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$763.52M+11.1%
Q2 FY2026CQ1 2026Mar 31, 2026$1.64B+128.6%
Q1 FY2026CQ4 2025Dec 31, 2025$559.65M+14.5%
Q4 FY2025CQ3 2025Sep 30, 2025-$339.70M-10144.5%
Q3 FY2025CQ2 2025Jun 30, 2025$687.40M+42.2%
Q2 FY2025CQ1 2025Mar 31, 2025$717.87M+70.6%
Q1 FY2025CQ4 2024Dec 31, 2024$488.60M-18.8%
Q4 FY2024CQ3 2024Sep 30, 2024$3.38M-99.0%
Q3 FY2024CQ2 2024Jun 30, 2024$483.46M+0.8%
Q2 FY2024CQ1 2024Mar 31, 2024$420.78M-3.4%
Q1 FY2024CQ4 2023Dec 31, 2023$601.50M+25.4%
Q4 FY2023CQ3 2023Sep 30, 2023$350.57M+18.9%
Q3 FY2023CQ2 2023Jun 30, 2023$479.58M+17.8%
Q2 FY2023CQ1 2023Mar 31, 2023$435.40M-20.5%
Q1 FY2023CQ4 2022Dec 31, 2022$479.75M+6.8%
Q4 FY2022CQ3 2022Sep 30, 2022$294.74M-32.7%
Q3 FY2022CQ2 2022Jun 30, 2022$406.96M+39.3%
Q2 FY2022CQ1 2022Mar 31, 2022$548.01M+25.9%
Q1 FY2022CQ4 2021Dec 31, 2021$449.11M+19.8%
Q4 FY2021CQ3 2021Sep 30, 2021$437.70M–
Q3 FY2021CQ2 2021Jun 30, 2021$292.12M+0.9%
Q2 FY2021CQ1 2021Mar 31, 2021$435.27M-54.7%
Q1 FY2021CQ4 2020Dec 31, 2020$374.85M+99.8%
Q4 FY2020CQ3 2020Sep 30, 2020-$4.85B-3754.1%
Q3 FY2020CQ2 2020Jun 30, 2020$289.44M-4.1%
Q2 FY2020CQ1 2020Mar 31, 2020$960.28M+3438.9%
Q1 FY2020CQ4 2019Dec 31, 2019$187.64M-52.3%
Q4 FY2019CQ3 2019Sep 30, 2019$132.62M-43.2%
Q3 FY2019CQ2 2019Jun 30, 2019$301.96M+9.5%
Q2 FY2019CQ1 2019Mar 31, 2019$27.14M-90.6%
Q1 FY2019CQ4 2018Dec 31, 2018$393.65M-54.3%
Q4 FY2018CQ3 2018Sep 30, 2018$233.29M–
Q3 FY2018CQ2 2018Jun 30, 2018$275.81M+447.8%
Q2 FY2018CQ1 2018Mar 31, 2018$287.46M-30.1%
Q1 FY2018CQ4 2017Dec 31, 2017$861.85M+248.6%
Q4 FY2017CQ3 2017Sep 30, 2017-$344.59M-336.5%
Q3 FY2017CQ2 2017Jun 30, 2017$50.35M–
Q2 FY2017CQ1 2017Mar 31, 2017$411.47M–
Q1 FY2017CQ4 2016Dec 31, 2016$247.25M–
Q4 FY2016CQ3 2016Sep 30, 2016$145.69M–

More Cencora figures

See a number that looks wrong?